Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells
Marjorie Côte, … , Alain Fischer, Geneviève de Saint Basile
Marjorie Côte, … , Alain Fischer, Geneviève de Saint Basile
Published November 2, 2009
Citation Information: J Clin Invest. 2009;119(12):3765-3773. https://doi.org/10.1172/JCI40732.
View: Text | PDF
Research Article Immunology

Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells

  • Text
  • PDF
Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous autosomal recessive immune disorder characterized by the occurrence of uncontrolled activation of lymphocytes and macrophages infiltrating multiple organs. Disease-causing mutations in the perforin (PRF1; also known as FHL2), Munc13-4 (UNC13D; also known as FHL3), and syntaxin-11 (STX11; also known as FHL4) genes have been identified in individuals with FHL. These genes all encode proteins involved in the cytotoxic activity of lymphocytes. Here, we show that the gene encoding syntaxin-binding protein 2 (Munc18-2; official gene symbol STXBP2) is mutated in another subset of patients with FHL (designated by us as “FHL5”). Lymphoblasts isolated from these patients had strongly decreased STXBP2 protein expression, and NK cells exhibited impaired cytotoxic granule exocytosis, a defect that could be overcome by ectopic expression of wild-type STXBP2. Furthermore, we provide evidence that syntaxin-11 is the main partner of STXBP2 in lymphocytes, as its expression required the presence of STXBP2. Our work shows that STXBP2 deficiency causes FHL5. These data indicate that STXBP2 is required at a late step of the secretory pathway for the release of cytotoxic granules by binding syntaxin 11, another component of the intracellular membrane fusion machinery.

Authors

Marjorie Côte, Mickaël M. Ménager, Agathe Burgess, Nizar Mahlaoui, Capucine Picard, Catherine Schaffner, Fahad Al-Manjomi, Musa Al-Harbi, Abdullah Alangari, Françoise Le Deist, Andrew R. Gennery, Nathalie Prince, Astrid Cariou, Patrick Nitschke, Ulrich Blank, Gehad El-Ghazali, Gaël Ménasché, Sylvain Latour, Alain Fischer, Geneviève de Saint Basile

×

Figure 4

Defective cytotoxic granule exocytosis of STXBP2-deficient NK lymphocytes.

Options: View larger image (or click on image) Download as PowerPoint
Defective cytotoxic granule exocytosis of STXBP2-deficient NK lymphocyte...
(A) Exocytosis of cytotoxic granules from resting or STXBP2-deficient CD3–CD56+ NK cells cultured with IL-2 for 72 hours (F5P1, triangle and F5P2, diamond) compared with cells of healthy adult and infant donors (controls). Cytotoxic granule exocytosis (ΔCD107) represents the percentage of CD107+ NK cells stimulated with anti-CD16 and P815 cells subtracted from the percentage of CD107+ NK cells incubated with P815 cells alone. Horizontal bars represent mean values. **P < 0.01, control values compared with the median value for each patient. (B) CD107 expression of NK cells cultured with IL-2 for 15–20 days from either controls or STXBP2-deficient (F5P1, F5P2, and F6P1) individuals. Values represent mean (± SD) percentages of the CD107+ NK cells. (C) Cytotoxic granule exocytosis by T lymphoblasts. Induced CD107 surface expression on CD3+CD8+ T lymphoblasts from controls, STXBP2-deficient individuals (F2P1, F5P1, and F6P1), or STX11-deficient individuals (P1 and P2). Horizontal bars represent mean values. #P > 0.1. (D) Restoration of the cytotoxic granule exocytosis in patient cells transfected with WT STXBP2 construct. PBMCs described in B were cotransfected with the WT STXBP2-FLAG–tagged vector or empty-FLAG–tagged vector and the insertless ECFP vector. For each individual, the ECFP-positive (transfected) and ECFP-negative (nontransfected) NK cell populations were tested as described in B. Dot plots were gated on CD3–CD56+ NK cells, and gates were set individually on the basis of NK cells incubated with P815 alone. Numbers indicate the percentage of degranulating NK cells. The results shown are representative of 2 independent experiments with similar results.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts